{"id":71470,"date":"2026-05-20T11:55:00","date_gmt":"2026-05-20T11:55:00","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=71470"},"modified":"2026-10-15T10:33:56","modified_gmt":"2026-10-15T10:33:56","slug":"l-glutathione-reduced-gsh","status":"publish","type":"product","link":"https:\/\/medsbase.com\/pt-pt\/product\/l-glutathione-reduced-gsh\/","title":{"rendered":"L-Glutathione (Reduced \/ GSH) Injectable \u2014 Pharmaceutical Grade"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Resposta R\u00e1pida \u2014 O que \u00e9 a Glutationa (GSH)?<\/h3>\n<p style=\"margin: 0;\"><strong>L-Glutationa (reduzida; GSH)<\/strong> \u00e9 o tripept\u00eddeo \u03b3-glutamil-cisteinil-glicina (\u03b3-Glu-Cys-Gly), CAS 70-18-8, f\u00f3rmula molecular C<sub>10<\/sub>H<sub>17<\/sub>N<sub>3<\/sub>O<sub>6<\/sub>S, MW 307.32 g\/mol. GSH is the most abundant non-protein cellular thiol (millimolar intracellular concentrations) and the canonical reference compound for cellular antioxidant defence studies. The unique <strong>liga\u00e7\u00e3o pept\u00eddica \u03b3<\/strong> between glutamate&#8217;s \u03b3-carboxyl and cysteine&#8217;s amino group (rather than the standard \u03b1-peptide bond) makes GSH resistant to common peptidases \u2014 only \u03b3-glutamyltransferase (\u03b3-GT) can cleave it. Cells use GSH as the primary electron donor for glutathione peroxidase-mediated hydrogen-peroxide reduction, as the conjugating co-substrate for glutathione-S-transferase-mediated xenobiotic detoxification, and as the redox-status buffer that controls protein thiol-disulfide equilibrium. Supplied here as lyophilized USP-grade powder for clinical studies use only.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>O que obt\u00e9m com a MedsBase:<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/pt-pt\/reviews\/\">de clientes<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Cada encomenda est\u00e1 coberta pela nossa <a href=\"https:\/\/medsbase.com\/pt-pt\/medsbase-re-shipment-assurance-policy\/\"><strong>Pol\u00edtica de Garantia de Reenvio<\/strong><\/a> \u2014 se a sua encomenda n\u00e3o chegar no prazo de 20 dias \u00fateis, reenviamo-la.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Especifica\u00e7\u00e3o<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detalhe<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Classe do Composto<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u03b3-Glutamyl tripeptide; primary cellular non-protein thiol antioxidant; small-molecule peptide (\u03b3-linked, peptidase-resistant)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Nome Qu\u00edmico<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">L-Glutationa, reduzida (\u03b3-L-Glutamil-L-cisteinil-glicina; sin\u00f3nimos: GSH, \u00e1cido livre de glutationa, glutationa reduzida)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>N\u00famero CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">70-18-8 (forma reduzida de GSH); relacionado: 27025-41-8 (forma dim\u00e9rica oxidada de GSSG, n\u00e3o fornecida aqui)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>F\u00f3rmula Molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>10<\/sub>H<sub>17<\/sub>N<sub>3<\/sub>O<sub>6<\/sub>S<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Peso Molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">307,32 g\/mol (\u00e1cido livre)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Sequ\u00eancia<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u03b3-L-Glutamil-L-cisteinil-glicina (\u03b3-Glu-Cys-Gly). Note a <strong>liga\u00e7\u00e3o pept\u00eddica \u03b3<\/strong> entre a cadeia lateral \u03b3-COOH do glutamato e o grupo \u03b1-amino da ciste\u00edna, em vez da liga\u00e7\u00e3o pept\u00eddica \u03b1 padr\u00e3o. Esta liga\u00e7\u00e3o n\u00e3o padr\u00e3o \u00e9 o que torna o GSH resistente \u00e0s \u03b1-peptidases comuns \u2014 apenas a \u03b3-glutamiltransferase (\u03b3-GT) o cliva, que \u00e9 o passo limitante da velocidade na degrada\u00e7\u00e3o e reciclagem extracelular do GSH.<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Mechanism<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\"><strong>Tr\u00eas fun\u00e7\u00f5es celulares prim\u00e1rias<\/strong>. (1) <em>Doador de eletr\u00f5es para a glutationa peroxidase<\/em> (Fam\u00edlia GPx) \u2014 2 GSH + H<sub>2<\/sub>O<sub>2<\/sub> \u2192 GSSG + 2 H<sub>2<\/sub>O, a rea\u00e7\u00e3o can\u00f3nica de redu\u00e7\u00e3o de per\u00f3xido de hidrog\u00e9nio celular; o GSSG \u00e9 ent\u00e3o reduzido de volta a 2 GSH pela glutationa redutase dependente de NADPH. (2) <em>Co-substrato para a glutationa-S-transferase<\/em> (Fam\u00edlia GST) \u2014 conjuga GSH a substratos xenobi\u00f3ticos e end\u00f3genos eletrof\u00edlicos, gerando conjugados de \u00e1cido mercapt\u00farico excret\u00e1veis (a via central de desintoxica\u00e7\u00e3o hep\u00e1tica). (3) <em>Tamp\u00e3o do estado redox<\/em> \u2014 a propor\u00e7\u00e3o GSH:GSSG (tipicamente ~100:1 em c\u00e9lulas saud\u00e1veis) controla o equil\u00edbrio tiol-dissulfureto das prote\u00ednas atrav\u00e9s da troca mediada por tiorredoxina e glutaredoxina, regulando milhares de atividades proteicas sens\u00edveis ao redox.<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forma<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyophilized white-to-off-white crystalline powder; single-use vials. <strong>Altamente higrosc\u00f3pico<\/strong> \u2014 feche os frascos imediatamente ap\u00f3s cada retirada para evitar a absor\u00e7\u00e3o de humidade.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Pureza<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (verificado por HPLC, COA dispon\u00edvel mediante pedido); titula\u00e7\u00e3o confirma \u226598% de GSH reduzido (\u22642% de GSSG oxidado). Refer\u00eancia USP.<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilidade<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u00c1gua 20 mg\/mL; PBS (pH 7,2) 10 mg\/mL \u2014 facilmente sol\u00favel nas concentra\u00e7\u00f5es fornecidas nos frascos. O grupo tiol (-SH) torna o GSH sens\u00edvel \u00e0 oxida\u00e7\u00e3o pelo ar \u2014 prepare solu\u00e7\u00f5es de trabalho frescas a partir do frasco liofilizado e utilize-as dentro de 24 horas, quando poss\u00edvel. O DMSO \u00e9 um co-solvente adequado para a prepara\u00e7\u00e3o de estoques de cultura celular (at\u00e9 100 mg\/mL) e fornece prote\u00e7\u00e3o adicional contra a oxida\u00e7\u00e3o pelo ar.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Armazenamento<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Liofilizado: 2\u20138 \u00b0C na embalagem original selada para estoque de trabalho de curto prazo; \u221220 \u00b0C para armazenamento de longo prazo de frascos n\u00e3o abertos (est\u00e1vel \u226536 meses a \u221220 \u00b0C; \u226518 meses a 2\u20138 \u00b0C). Solu\u00e7\u00f5es aquosas reconstitu\u00eddas: 2\u20138 \u00b0C, utilize dentro de ~7 dias (a oxida\u00e7\u00e3o pelo ar para GSSG \u00e9 o fator limitante). Proteja da luz. <strong>Evitar ciclos repetidos de congela\u00e7\u00e3o-descongela\u00e7\u00e3o de solu\u00e7\u00f5es reconstitu\u00eddas<\/strong> \u2014 os ciclos cumulativos aceleram a oxida\u00e7\u00e3o de GSH \u2192 GSSG.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>O Que \u00c9 L-Glutationa (Reduzida\/GSH)?<\/h2>\n<p><strong>L-Glutationa (forma reduzida, GSH)<\/strong> \u00e9 o tiol celular n\u00e3o proteico mais abundante na biologia eucari\u00f3tica \u2014 presente em concentra\u00e7\u00f5es intracelulares milimolares (1\u201310 mM na maioria dos tipos celulares; at\u00e9 10 mM em hepat\u00f3citos) e servindo como o principal tamp\u00e3o molecular para o estado redox celular. Estruturalmente, \u00e9 um tripept\u00eddeo de glutamato, ciste\u00edna e glicina (\u03b3-Glu-Cys-Gly), CAS 70-18-8, f\u00f3rmula molecular C<sub>10<\/sub>H<sub>17<\/sub>N<sub>3<\/sub>O<sub>6<\/sub>S, molecular weight 307.32 g\/mol. The defining structural feature of glutathione is its <strong>liga\u00e7\u00e3o pept\u00eddica \u03b3<\/strong>. Liga\u00e7\u00e3o \u03b3-glutamil. Os pept\u00eddeos padr\u00e3o est\u00e3o ligados atrav\u00e9s de liga\u00e7\u00f5es pept\u00eddicas \u03b1 entre o \u03b1-carboxilo de um amino\u00e1cido e o \u03b1-amino do seguinte. Na glutationa, a liga\u00e7\u00e3o entre o glutamato e a ciste\u00edna \u00e9 n\u00e3o convencional: \u00e9 formada entre o <em>\u03b3-carboxilo<\/em> of glutamate&#8217;s side chain and the \u03b1-amino of cysteine. This non-standard linkage is the molecular basis for glutathione&#8217;s resistance to common cellular peptidases \u2014 only \u03b3-glutamyltransferase (\u03b3-GT, GGT, EC 2.3.2.2) recognises and cleaves the \u03b3-bond. As a result, glutathione is uniquely stable in the cellular cytosol where it would otherwise be rapidly degraded by \u03b1-peptidase activity, and \u03b3-GT-mediated extracellular degradation is the rate-limiting step of glutathione recycling. Glutathione is synthesised in two ATP-dependent steps by the cytosolic enzymes <strong>glutamato-ciste\u00edna ligase (GCL)<\/strong> \u2014 que forma a liga\u00e7\u00e3o \u03b3-glutamil-ciste\u00edna \u2014 e <strong>glutationa sintetase (GSS)<\/strong> \u2014 which adds the C-terminal glycine. GCL is the rate-limiting enzyme and is feedback-inhibited by glutathione itself, providing autoregulation of cellular glutathione levels. Cysteine availability is the other major rate-limiting input \u2014 which is why N-acetylcysteine (NAC), a cysteine prodrug, is the canonical clinical intervention for boosting cellular glutathione synthesis in oxidative-stress and detoxification contexts (the basis of NAC&#8217;s approval for paracetamol overdose and other clinical indications). Glutathione exists in cells in two interconverting forms: the <strong>forma reduzida (GSH)<\/strong> com um grupo tiol livre (-SH), e a <strong>forma oxidada (GSSG)<\/strong> onde duas mol\u00e9culas de GSH est\u00e3o ligadas por uma ponte dissulfureto. A propor\u00e7\u00e3o GSH:GSSG (tipicamente ~100:1 em c\u00e9lulas saud\u00e1veis, diminuindo para 10:1 ou menos sob stresse oxidativo) \u00e9 o biomarcador redox celular can\u00f3nico. O GSSG \u00e9 reduzido de volta a 2 GSH pela <strong>glutationa redutase (GR, GSR)<\/strong>, an NADPH-dependent flavoenzyme \u2014 connecting the GSH redox system to NADPH availability and ultimately to the pentose phosphate pathway. This is why pentose-phosphate-pathway disruption (G6PD deficiency, glucose-6-phosphate availability) impairs GSH-system function and triggers oxidative cell damage. The pharmaceutical-grade material supplied here is the reduced GSH form, supplied as lyophilized powder for reconstitution and protocol use alongside the peptide catalogue. <\/p>\n<h2>Mecanismo de A\u00e7\u00e3o \u2014 Tr\u00eas Fun\u00e7\u00f5es Celulares Prim\u00e1rias<\/h2>\n<p>O mecanismo biol\u00f3gico da GSH \u00e9 a soma de tr\u00eas fun\u00e7\u00f5es celulares prim\u00e1rias, todas bem caracterizadas na bioqu\u00edmica publicada:<\/p>\n<ul>\n<li><strong>Substrato da glutationa peroxidase (GPx) \u2014 redu\u00e7\u00e3o do per\u00f3xido de hidrog\u00e9nio e dos per\u00f3xidos lip\u00eddicos<\/strong> \u2014 A fun\u00e7\u00e3o mais citada da GSH. A fam\u00edlia GPx (GPx1\u20138, sendo a GPx1 dependente de sel\u00e9nio a mais abundante) catalisa a rea\u00e7\u00e3o <em>2 GSH + ROOH \u2192 GSSG + ROH + H<sub>2<\/sub>O<\/em>, reduzindo o per\u00f3xido de hidrog\u00e9nio e os hidroper\u00f3xidos lip\u00eddicos a \u00e1gua e \u00e1lcoois, respetivamente. Esta \u00e9 a principal defesa da c\u00e9lula contra as esp\u00e9cies reativas de oxig\u00e9nio geradas pela respira\u00e7\u00e3o mitocondrial, atividade da NADPH-oxidase e outros processos oxidativos. A GPx4 \u00e9 a isoforma espec\u00edfica que catalisa a redu\u00e7\u00e3o dos hidroper\u00f3xidos lip\u00eddicos e \u00e9 o alvo molecular cuja perda de fun\u00e7\u00e3o desencadeia <strong>ferroptose<\/strong> \u2014 the iron-dependent regulated cell death pathway that has become a major focus of recent cancer-studies and neurodegenerative-disease studies.<\/li>\n<li><strong>Co-substrato da glutationa-S-transferase (GST) \u2014 conjuga\u00e7\u00e3o de xenobi\u00f3ticos e endobi\u00f3ticos<\/strong> \u2014 A fam\u00edlia GST (membros citos\u00f3licos, microsomais e mitocondriais; ~20 isoformas humanas de GST) catalisa a conjuga\u00e7\u00e3o da GSH a substratos eletrof\u00edlicos atrav\u00e9s do grupo tiol da GSH, gerando aductos de conjugado GSH-S que s\u00e3o subsequentemente processados pela \u03b3-GT e dipeptidases em \u00e1cidos mercapt\u00faricos e excretados. Esta \u00e9 a principal via de desintoxica\u00e7\u00e3o de Fase II no f\u00edgado e outros tecidos, processando uma vasta gama de xenobi\u00f3ticos (metabolitos de f\u00e1rmacos, qu\u00edmicos ambientais, produtos do metabolismo de Fase I do citocromo-P450), eletr\u00f3filos end\u00f3genos (4-hidroxinonenal, acrole\u00edna proveniente da peroxida\u00e7\u00e3o lip\u00eddica) e intermedi\u00e1rios reativos (NAPQI do paracetamol, a base da terapia com NAC em overdose de paracetamol).<\/li>\n<li><strong>Tamp\u00e3o do estado redox \u2014 regula\u00e7\u00e3o do equil\u00edbrio tiol-dissulfureto das prote\u00ednas<\/strong> \u2014 The cellular GSH:GSSG ratio sets the thermodynamic equilibrium for protein-thiol redox state via thioredoxin- and glutaredoxin-mediated exchange. Thousands of cellular proteins have redox-sensitive cysteine residues whose thiol-disulfide state is regulated by this equilibrium \u2014 including key transcription factors (NF-\u03baB, AP-1, Nrf2, p53), signalling kinases (PTPs, PTEN), apoptosis machinery (caspases), and metabolic enzymes (glyceraldehyde-3-phosphate dehydrogenase, others). GSH-mediated redox buffering is therefore not just an antioxidant defence but a signalling regulatory mechanism \u2014 a fact that has emerged in published studies over the past two decades and is one of the most-cited rationales for the use of GSH in protocols beyond simple antioxidant supplementation.<\/li>\n<li><strong>Reservat\u00f3rio de ciste\u00edna e tr\u00e1fego inter-org\u00e2nico de amino\u00e1cidos<\/strong> \u2014 A GSH serve como um reservat\u00f3rio tecidual est\u00e1vel e transport\u00e1vel de ciste\u00edna \u2014 o amino\u00e1cido limitante para a s\u00edntese de novas prote\u00ednas e para a s\u00edntese adicional de GSH. A ciste\u00edna na forma livre \u00e9 metabolicamente inst\u00e1vel (auto-oxida-se a cistina, pode gerar H<sub>2<\/sub>S, etc.), pelo que o organismo mant\u00e9m o seu pool de ciste\u00edna maioritariamente como GSH e transporta ciste\u00edna entre \u00f3rg\u00e3os (especialmente f\u00edgado \u2192 rim, f\u00edgado \u2192 outros tecidos) como GSH, que \u00e9 depois processada de volta a ciste\u00edna pela \u03b3-GT no tecido alvo.<\/li>\n<li><strong>Capta\u00e7\u00e3o direta de radicais<\/strong> \u2014 Para al\u00e9m das fun\u00e7\u00f5es enzim\u00e1ticas, o GSH reage diretamente com o radical hidroxilo, o radical peroxilo e as esp\u00e9cies reativas de azoto atrav\u00e9s do grupo tiol. Quantitativamente, isto contribui menos para a defesa antioxidante total do que o mecanismo mediado pela enzima GPx, mas \u00e9 importante em compartimentos e condi\u00e7\u00f5es onde os sistemas enzim\u00e1ticos est\u00e3o saturados ou ausentes (GSH extracelular no fluido de revestimento pulmonar, GSH no l\u00famen intestinal, etc.).<\/li>\n<\/ul>\n<p>The pharmacokinetic profile of injectable GSH is well-characterised: IV administration produces rapid systemic distribution with peak plasma concentrations within minutes, but plasma half-life is short (~10\u201315 minutes) due to rapid \u03b3-GT-mediated breakdown to cysteinylglycine and subsequent re-synthesis or further breakdown at target tissues. The brief plasma residence is one of the reasons why daily or twice-daily IV dosing protocols are common in published GSH studies. Cell-membrane permeability of intact GSH is low \u2014 cells primarily import the constituent amino acids and re-synthesise GSH intracellularly. This is why oral GSH is poorly bioavailable and why injectable preparations (or alternatively NAC as a cysteine prodrug) are required for effective tissue delivery in published studies. <\/p>\n<h2>Published Evidence<\/h2>\n<p>GSH is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>Defesa antioxidante celular \u2014 o composto de refer\u00eancia can\u00f3nico<\/strong> \u2014 by far the most-cited cellular antioxidant in the published literature; standard reference compound for any new antioxidant intervention studies; the molecular gold standard for cellular redox-status analysis<\/li>\n<li><strong>Hydrogen peroxide and lipid peroxide reduction studies<\/strong> \u2014 direct GPx substrate; used in published studies on GPx isoform pharmacology, peroxide-handling pathway dissection, and the integration of GSH with thioredoxin and peroxiredoxin redox systems<\/li>\n<li><strong>Ferroptosis studies<\/strong> \u2014 GPx4-mediated lipid-hydroperoxide reduction is the gatekeeper of ferroptosis; GSH and its synthesis-pathway interventions (BSO, erastin, RSL3) are the canonical tools for ferroptosis induction \/ suppression studies in cancer, neurodegeneration, and ischaemia-reperfusion contexts<\/li>\n<li><strong>Phase II detoxification and xenobiotic-conjugation studies<\/strong> \u2014 GST substrate for the central liver-detoxification pathway; used in studies on drug-metabolite handling, environmental-chemical exposure, paracetamol-induced hepatotoxicity (NAPQI scavenging), and the broader pharmacology of mercapturic-acid conjugation<\/li>\n<li><strong>Protein-thiol redox signalling studies<\/strong> \u2014 the GSH:GSSG ratio controls thiol-disulfide equilibrium of thousands of cellular proteins; used in studies on redox-sensitive transcription factors (Nrf2, NF-\u03baB, AP-1), kinase regulation (PTPs, PTEN), and the broader cellular &#8220;redoxome&#8221;<\/li>\n<li><strong>Mitochondrial dysfunction and ageing studies<\/strong> \u2014 mitochondrial GSH levels decline with age and in many disease models; published studies uses exogenous GSH and GSH-pathway interventions to probe mitochondrial-redox contributions to ageing, neurodegeneration, and metabolic disease<\/li>\n<li><strong>Hepatology and liver-injury studies<\/strong> \u2014 GSH is most abundant in hepatocytes (5\u201310 mM concentration); used in published studies on alcoholic liver disease, NAFLD\/MASH, viral hepatitis models, and paracetamol-overdose \/ drug-induced liver injury<\/li>\n<li><strong>Hematology and erythrocyte studies<\/strong> \u2014 erythrocyte GSH is the major defence against oxidative haemolysis; used in studies on G6PD deficiency, sickle-cell disease, oxidative haemolysis pharmacology<\/li>\n<li><strong>Cancer redox and chemoprotection studies<\/strong> \u2014 many chemotherapeutic drugs generate ROS as part of their mechanism, and tumour cells often have elevated GSH levels; published studies uses GSH and GSH-pathway interventions to dissect chemotherapy redox biology<\/li>\n<\/ul>\n<p>For broader context on cellular cofactor and redox \/ antioxidant compounds in this catalogue, see <a href=\"https:\/\/medsbase.com\/pt-pt\/b12-cyanocobalamin\/\">B12 (Cianocobalamina)<\/a> (small-molecule companion cofactor \u2014 methylation cycle), <a href=\"https:\/\/medsbase.com\/pt-pt\/l-carnitine\/\">L-Carnitina<\/a> (pequena mol\u00e9cula companheira \u2014 transporte de \u00e1cidos gordos mitocondriais), <a href=\"https:\/\/medsbase.com\/pt-pt\/nad\/\">NAD\u207a<\/a> (suplementa\u00e7\u00e3o direta do pool de dinucle\u00f3tidos \u2014 transporte de eletr\u00f5es redox), <a href=\"https:\/\/medsbase.com\/pt-pt\/5-amino-1mq\/\">5-Amino-1MQ<\/a> (Poupan\u00e7a do eixo NAD atrav\u00e9s da inibi\u00e7\u00e3o da NNMT), e <a href=\"https:\/\/medsbase.com\/pt-pt\/ss-31-elamipretide\/\">SS-31 (Elamipretide)<\/a> (Pept\u00eddeo antioxidante direcionado para mitoc\u00f4ndrias com liga\u00e7\u00e3o \u00e0 cardiolipina). Navegue pelo <a href=\"https:\/\/medsbase.com\/pt-pt\/peptides\/\">peptides &amp; compounds catalog<\/a>, ou consulte a sele\u00e7\u00e3o <a href=\"https:\/\/medsbase.com\/pt-pt\/best-longevity-peptides\/\">longevity compounds<\/a> hub. <\/p>\n<h2>For\u00e7as e Concentra\u00e7\u00f5es Dispon\u00edveis<\/h2>\n<p>MedsBase stocks Glutathione in three lyophilized vial sizes calibrated to typical protocol dose ranges. Each strength is available in 10-vial, 20-vial, or 30-vial pack formats:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">For\u00e7a do frasco<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Caso de uso t\u00edpico<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Tamanhos das embalagens<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>600 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength \u2014 entry-level protocols, in-vitro antioxidant-defence panels, dose-titration work, single-cohort murine titration; convenient for reconstitution at 100\u2013200 mg\/mL working stocks<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 frascos<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>900 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Mid-strength \u2014 extended in-vivo rodent dosing protocols, IV-protocols, multi-cohort sample sizes, hepatology \/ oxidative-stress model studies<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 frascos<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>1500 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">High-strength vial \u2014 clinical-translational dose-range protocols (Italian Tationil IV dosing is 600\u20132400 mg\/d for hepatology studies), large-cohort metabolic studies, multi-arm comparator work; lowest per-mg cost<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 frascos<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>All three strengths are the same chemical entity (lyophilized L-glutathione reduced form, \u226599% HPLC purity, USP-grade titration-confirmed reduced-form content). The 1500 mg vial provides the lowest per-mg cost for clinical-translational protocols. Users should determine specific dose ranges from peer-reviewed literature appropriate to the protocol. <\/p>\n<h2>Como Compara \u2014 Glutationa vs NAD\u207a<\/h2>\n<p>Glutationa e <a href=\"https:\/\/medsbase.com\/pt-pt\/nad\/\">NAD\u207a<\/a> s\u00e3o os dois compostos redox celulares \/ coenzimas de pequena mol\u00e9cula mais estudados neste cat\u00e1logo, e situam-se em ramos conectados mas mecanicamente distintos da biologia redox celular. A GSH \u00e9 a principal <em>defesa antioxidante celular<\/em> de pequena mol\u00e9cula \u2014 presente em concentra\u00e7\u00f5es milimolares e reduzindo per\u00f3xidos atrav\u00e9s do mecanismo de substrato GPx. O NAD\u207a \u00e9 a principal <em>coenzima de transporte de el\u00e9trons<\/em> coenzyme \u2014 reducible to NADH for electron transport in glycolysis \/ TCA cycle \/ \u03b2-oxidation, and substrate for sirtuins and PARPs. The two systems are interconnected: NADPH (made from NAD via the pentose phosphate pathway) is the reducing equivalent that regenerates GSH from GSSG via glutathione reductase. Studies that probes cellular redox biology often manipulates both pools and compares the consequences. <\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Crit\u00e9rio<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Glutationa (GSH)<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">NAD\u207a<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Classe qu\u00edmica<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u03b3-Glutamil tripept\u00eddeo (\u03b3-Glu-Cys-Gly)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Dinucle\u00f3tido coenzima (adenina + nicotinamida + difosfato)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Peso molecular<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">307.32 g\/mol<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">663.43 g\/mol<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Papel celular<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Defesa antioxidante \u2014 substrato da GPx (redu\u00e7\u00e3o de per\u00f3xido), co-substrato da GST (conjuga\u00e7\u00e3o de xenobi\u00f3ticos), tamp\u00e3o do estado redox<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Coenzima de transporte de eletr\u00f5es \u2014 substrato para \u03b2-oxida\u00e7\u00e3o, glic\u00f3lise, TCA; substrato para sirtu\u00ednas e PARPs<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Concentra\u00e7\u00e3o celular<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">1\u201310 mM (milimolar \u2014 tiol n\u00e3o proteico mais abundante)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~0.3\u20131 mM (pool de NAD, micromolar a \u00b5M elevado)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Best-studied studies focus<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Defesa antioxidante, ferroptose, desintoxica\u00e7\u00e3o da Fase II, sinaliza\u00e7\u00e3o redox, hepatologia, les\u00e3o induzida por paracetamol<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Biologia das sirtu\u00ednas, longevidade, envelhecimento celular, regula\u00e7\u00e3o redox do eixo NAD<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Estabilidade no plasma<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Curto \u2014 meia-vida de ~10\u201315 min (degrada\u00e7\u00e3o extracelular mediada pela \u03b3-GT)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Muito curto \u2014 minutos (oxida e degrada rapidamente em solu\u00e7\u00e3o)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Conex\u00e3o<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">NADPH (derivado do NAD) regenera GSH a partir de GSSG via glutationa redutase<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">A conex\u00e3o do NADPH liga o pool de NAD \u00e0 capacidade de redu\u00e7\u00e3o do sistema GSH<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Uso cl\u00ednico<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Injet\u00e1vel aprovado em It\u00e1lia \/ Jap\u00e3o \/ Coreia (Tationil e similares; hepatologia, stress oxidativo)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Not approved as a clinical therapeutic; studies-only compound<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For studies focused on cellular antioxidant defence, ferroptosis, Phase II detoxification, or redox signalling, Glutathione is the canonical reference compound. For studies focused on sirtuin biology, longevity-axis biochemistry, or NAD-dependent redox regulation, <a href=\"https:\/\/medsbase.com\/pt-pt\/nad\/\">NAD\u207a<\/a> is the more targeted tool. The two compounds are commonly co-administered in studies that probes the integrated cellular-redox-system response to oxidative stress, ageing, or mitochondrial dysfunction. <\/p>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 14px 18px; margin: 18px 0;\"><strong class=\"mb-bac-water-callout\">\ud83d\udca7 Precisa de \u00e1gua BAC?<\/strong> A reconstitui\u00e7\u00e3o de qualquer frasco liofilizado requer \u00e1gua bacteriost\u00e1tica est\u00e9ril. Combine este produto com o nosso <a href=\"\/pt-pt\/bac-water\/\"><strong>\u00c1gua BAC (\u00c1gua Bacteriost\u00e1tica)<\/strong><\/a> \u2014 frasco multidose de 30 mL, conservado com 0,9% de \u00e1lcool benz\u00edlico, grau USP.<\/div>\n<h2>Armazenamento e Reconstitui\u00e7\u00e3o<\/h2>\n<p><strong>Antes da reconstitui\u00e7\u00e3o:<\/strong> armazene frascos liofilizados refrigerados a 2\u20138 \u00b0C na embalagem original selada. Para armazenamento a longo prazo, congele frascos n\u00e3o abertos a \u221220 \u00b0C (est\u00e1vel \u226536 meses a \u221220 \u00b0C; \u226518 meses a 2\u20138 \u00b0C). A GSH liofilizada \u00e9 <strong>altamente higrosc\u00f3pica<\/strong> \u2014 re-sele os frascos imediatamente ap\u00f3s cada retirada para evitar a absor\u00e7\u00e3o de humidade (o que acelera a oxida\u00e7\u00e3o GSH \u2192 GSSG). Proteja da luz. <strong>Procedimento de reconstitui\u00e7\u00e3o:<\/strong> injete \u00e1gua est\u00e9ril, \u00e1gua bacteriost\u00e1tica ou PBS (pH 7,2) pela parede lateral do frasco (n\u00e3o diretamente sobre o comprimido liofilizado). Para um frasco de 600 mg, 6,0 mL de diluente produzem uma solu\u00e7\u00e3o de trabalho de 100 mg\/mL; 3,0 mL produzem 200 mg\/mL. Para um frasco de 900 mg, 9,0 mL produzem 100 mg\/mL; 4,5 mL produzem 200 mg\/mL. Para um frasco de 1500 mg, 7,5 mL produzem uma solu\u00e7\u00e3o de 200 mg\/mL; 15 mL produzem 100 mg\/mL. A GSH dissolve-se rapidamente com agita\u00e7\u00e3o suave \u00e0 temperatura ambiente. <strong>Cr\u00edtico para GSH reconstitu\u00eddo:<\/strong> o grupo tiol (-SH) \u00e9 <strong>sens\u00edvel \u00e0 oxida\u00e7\u00e3o pelo ar<\/strong> \u2014 as solu\u00e7\u00f5es reconstitu\u00eddas oxidam-se progressivamente para a forma GSSG, mesmo refrigeradas. Prepare solu\u00e7\u00f5es de trabalho frescas a partir de frascos liofilizados sempre que poss\u00edvel, ou utilize-as no prazo de 7 dias ap\u00f3s a reconstitui\u00e7\u00e3o, refrigeradas. Para armazenamento a longo prazo de material reconstitu\u00eddo, adicione quelantes (1 mM de EDTA) para retardar a oxida\u00e7\u00e3o catalisada por metais, armazene em atmosfera inerte (com \u00e1rgon ou purgado com azoto), ou utilize co-solvente DMSO (que fornece prote\u00e7\u00e3o adicional). N\u00e3o submeta a ciclos repetidos de congela\u00e7\u00e3o-descongela\u00e7\u00e3o. Descarte se ocorrer altera\u00e7\u00e3o de cor marcada (amarelo\/castanho) ou aparecimento de precipita\u00e7\u00e3o. <\/p>\n<h2>Perguntas Frequentes<\/h2>\n<h3>Qual \u00e9 a diferen\u00e7a entre glutationa reduzida (GSH) e oxidada (GSSG)?<\/h3>\n<p>GSH is the reduced form with a free thiol (-SH) group on its cysteine residue \u2014 the biologically active form that serves as the cellular antioxidant. GSSG is the oxidised dimer form where two GSH molecules are linked through their cysteine sulfurs by a disulfide bridge \u2014 the spent form that needs to be re-reduced to 2 GSH by glutathione reductase. The cellular GSH:GSSG ratio (typically ~100:1 in healthy cells, dropping to 10:1 or lower under oxidative stress) is the canonical biomarker of cellular redox status. We supply the reduced GSH form; users requiring GSSG specifically should consult dedicated suppliers. <\/p>\n<h3>Porque \u00e9 que a GSH tem uma liga\u00e7\u00e3o pept\u00eddica \u03b3 em vez de uma liga\u00e7\u00e3o pept\u00eddica \u03b1 normal?<\/h3>\n<p>A liga\u00e7\u00e3o pept\u00eddica n\u00e3o padr\u00e3o \u03b3 entre o \u03b3-COOH do glutamato e o \u03b1-NH2 da ciste\u00edna<sub>2<\/sub> \u00e9 o que confere \u00e0 glutationa a sua resist\u00eancia \u00e0s peptidases celulares. As \u03b1-peptidases celulares padr\u00e3o (aminopeptidases, carboxipeptidases) apenas reconhecem liga\u00e7\u00f5es pept\u00eddicas \u03b1 e n\u00e3o conseguem clivar a liga\u00e7\u00e3o \u03b3. Apenas a \u03b3-glutamiltransferase (\u03b3-GT, GGT) reconhece e cliva a liga\u00e7\u00e3o \u03b3 \u2014 e a \u03b3-GT \u00e9 a enzima limitante da degrada\u00e7\u00e3o da GSH, expressa principalmente na superf\u00edcie apical de c\u00e9lulas epiteliais (rim, trato biliar, etc.). Esta liga\u00e7\u00e3o n\u00e3o padr\u00e3o \u00e9, portanto, essencial para a acumula\u00e7\u00e3o intracelular est\u00e1vel da glutationa em concentra\u00e7\u00f5es milimolares. <\/p>\n<h3>Porque \u00e9 que a biodisponibilidade oral da GSH \u00e9 baixa?<\/h3>\n<p>Intact GSH is poorly absorbed across the intestinal epithelium because: (1) the \u03b3-peptide bond prevents recognition by the standard PEPT1 \/ PEPT2 di-\/tri-peptide transporters that absorb other tripeptides; (2) \u03b3-GT activity at the brush border degrades much of the orally-administered GSH to its constituent amino acids before absorption; (3) the cysteine that is liberated is then largely consumed by enterocyte first-pass GSH re-synthesis. The net oral bioavailability of intact GSH is therefore very low, which is why injectable preparations or N-acetylcysteine (NAC, a cysteine prodrug) are preferred for systemic GSH-boosting studies interventions. <\/p>\n<h3>What published dose ranges have been used in studies?<\/h3>\n<p>Injectable IV GSH protocol dosing typically uses 600\u20131200 mg per dose, daily or 2\u20133\u00d7\/week, for 4\u201312 weeks in human-subject studies (mirroring the Italian Tationil approved-product dose range of 600\u20132400 mg\/d). Rodent in-vivo work uses 50\u2013150 mg\/kg IV \/ IP, mirroring the dose range that produces reliable systemic GSH elevation despite the short plasma half-life. In-vitro cell-culture protocols typically use 0.5\u201310 mM in growth medium (cells take up cysteine from GSH and re-synthesise intracellular GSH). Users should consult primary literature appropriate to the specific application. <\/p>\n<h3>Porque \u00e9 que a meia-vida plasm\u00e1tica da GSH \u00e9 t\u00e3o curta?<\/h3>\n<p>Plasma \u03b3-GT activity rapidly cleaves the \u03b3-peptide bond of circulating GSH to cysteinylglycine, which is then further cleaved by dipeptidases to cysteine + glycine. The combined \u03b3-GT + dipeptidase cascade gives intact circulating GSH a plasma half-life of only ~10\u201315 minutes. This is why repeated daily dosing is used in clinical-protocols rather than single high-dose bolus regimens, and why N-acetylcysteine (NAC) \u2014 which is taken up intact and used for intracellular GSH synthesis \u2014 is sometimes preferred as a longer-acting cysteine-source alternative for cellular GSH boosting studies. <\/p>\n<h3>Can GSH be combined with B12, NAC, or other redox \/ cofactor compounds in protocols?<\/h3>\n<p>Yes \u2014 GSH is mechanistically connected to many other cellular-redox and cofactor compounds. Common protocol combinations include: GSH + NAC (parallel cysteine-source strategies \u2014 GSH as the intact tripeptide, NAC as the cysteine prodrug \u2014 to compare extracellular vs intracellular GSH-supplementation routes); GSH + <a href=\"https:\/\/medsbase.com\/pt-pt\/b12-cyanocobalamin\/\">B12<\/a> (oxidative-stress-related neurology and methylation-cycle studies); GSH + <a href=\"https:\/\/medsbase.com\/pt-pt\/nad\/\">NAD\u207a<\/a> (dissec\u00e7\u00e3o integrada da piscina redox); GSH + <a href=\"https:\/\/medsbase.com\/pt-pt\/ss-31-elamipretide\/\">SS-31<\/a> (mitochondrial-targeted redox studies). Reconstitute each separately just before use and add separately rather than co-storing reconstituted solutions. <\/p>\n<h3>How does this pharmaceutical-grade GSH compare with clinical preparations like Tationil?<\/h3>\n<p>Tationil (and similar branded clinical preparations available in Italy \/ Japan \/ Korea \/ Philippines) is reduced-form L-glutathione approved as a clinical injectable for hepatology and oxidative-stress indications. The pharmaceutical-grade GSH supplied here is the same reduced-form L-glutathione at \u226599% HPLC purity, supplied without a clinical-use label and intended for clinical studies only. Users seeking clinical-use GSH should obtain it through a clinical supply chain; users seeking pharmaceutical-grade material for in-vitro and in-vivo clinical protocols can use the material supplied here. <\/p>\n<h3>O GSH est\u00e1 na Lista de Subst\u00e2ncias Proibidas da WADA?<\/h3>\n<p>N\u00e3o. A glutationa n\u00e3o est\u00e1 na Lista de Subst\u00e2ncias Proibidas da WADA. \u00c9 um tripept\u00eddeo antioxidante celular naturalmente presente em concentra\u00e7\u00f5es milimolares em todas as c\u00e9lulas nucleadas \u2014 portanto, n\u00e3o est\u00e1 sujeita a restri\u00e7\u00f5es regulat\u00f3rias de desempenho atl\u00e9tico. <!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Small-Molecule Companion Compounds<\/h2>\n<ul>\n<li><a href=\"\/pt-pt\/b12-cyanocobalamin\/\"><strong>B12 (Cianocobalamina)<\/strong><\/a> \u2014 Cobalamin coenzyme \u2014 methylation-cycle companion<\/li>\n<li><a href=\"\/pt-pt\/l-carnitine\/\"><strong>L-Carnitina<\/strong><\/a> \u2014 Mitochondrial fatty-acid shuttle \u2014 closest small-molecule companion analogue<\/li>\n<li><a href=\"\/pt-pt\/nad\/\"><strong>NAD\u207a<\/strong><\/a> \u2014 Oxidised dinucleotide coenzyme \u2014 direct NAD-pool \/ electron-transport studies<\/li>\n<li><a href=\"\/pt-pt\/5-amino-1mq\/\"><strong>5-Amino-1MQ<\/strong><\/a> \u2014 Inibidor de NNMT \u2014 poupan\u00e7a de precursor do eixo NAD, tamponamento do pool de metila\u00e7\u00e3o<\/li>\n<li><a href=\"\/pt-pt\/ss-31-elamipretide\/\"><strong>SS-31 (Elamipretide)<\/strong><\/a> \u2014 Pept\u00eddeo antioxidante direcionado \u00e0s mitoc\u00f4ndrias ligado \u00e0 cardiolipina<\/li>\n<li><a href=\"\/pt-pt\/bac-water\/\"><strong>\u00c1gua BAC (\u00c1gua Bacteriost\u00e1tica)<\/strong><\/a> \u2014 Necess\u00e1rio para reconstituir qualquer frasco liofilizado \u2014 diluente est\u00e9ril, conservado com 0,9% de \u00e1lcool benz\u00edlico<\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Tripept\u00eddeo \u03b3-glutamil (\u03b3-Glu-Cis-Gli) \u2014 principal tiol n\u00e3o proteico celular<br \/>\n\u2705 Substrato de GPx (redu\u00e7\u00e3o de per\u00f3xido) + co-substrato de GST (conjuga\u00e7\u00e3o de xenobi\u00f3ticos) + tamp\u00e3o de estado redox<br \/>\n\u2705 Liga\u00e7\u00e3o pept\u00eddica \u03b3 \u00fanica \u2014 resistente a peptidases; apenas a \u03b3-GT a cliva<br \/>\n\u2705 Canonical reference compound for cellular antioxidant defence studies<br \/>\n\u2705 Forma reduzida liofilizada de grau USP; CAS 70-18-8, PM 307.32<\/p>\n<p><strong>L-Glutati\u00e3o (Reduzido\/GSH)<\/strong> contains the \u03b3-glutamyl-cysteinyl-glycine tripeptide compound.<\/p>","protected":false},"featured_media":71535,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[6517,6516,5737,4442,6519,6494,6518],"class_list":["post-71470","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-antioxidant-peptide","product_tag-glutathione-reduced","product_tag-gsh","product_tag-l-glutathione","product_tag-redox-research","product_tag-research-peptide","product_tag-tripeptide-research-compound","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product\/71470","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/comments?post=71470"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/media\/71535"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/media?parent=71470"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product_brand?post=71470"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product_cat?post=71470"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product_tag?post=71470"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}